PozNews - HIV News - STD News: Panacos Presents Phase 2b Bevirimat Data At The 48th Annual Interscience Conference On Antimicrobial Agents And Chemotherapy

Panacos Presents Phase 2b Bevirimat Data At The 48th Annual Interscience
Conference On Antimicrobial Agents And Chemotherapy
================================================================================
Medical News Today on 28 October, 2008 12:00:00
 
Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated
to developing the next generation of antiviral therapeutic products, today
announced that data from the Company's Phase 2b study of bevirimat, Panacos'
lead HIV-1 Gag maturation inhibitor, was shown in an oral presentation at the
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in
Washington, DC.